Nordea Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.25M | Buy |
127,500
+900
| +0.7% | +$44.1K | 0.01% | 522 |
|
|
2025
Q1 | $4.31M | Buy |
126,600
+1,200
| +1% | +$40.9K | ﹤0.01% | 565 |
|
|
2024
Q4 | $4.91M | Buy |
125,400
+5,300
| +4% | +$208K | 0.01% | 540 |
|
|
2024
Q3 | $5.66M | Sell |
120,100
-6,800
| -5% | -$320K | 0.01% | 508 |
|
|
2024
Q2 | $6.9M | Sell |
126,900
-21,800
| -15% | -$1.19M | 0.01% | 467 |
|
|
2024
Q1 | $10.3M | Buy |
148,700
+43,100
| +41% | +$2.99M | 0.01% | 418 |
|
|
2023
Q4 | $6.68M | Sell |
105,600
-2,500
| -2% | -$158K | 0.01% | 476 |
|
|
2023
Q3 | $5.04M | Buy |
108,100
+12,800
| +13% | +$597K | 0.01% | 501 |
|
|
2023
Q2 | $5.49M | Sell |
95,300
-5,900
| -6% | -$340K | 0.01% | 501 |
|
|
2023
Q1 | $4.55M | Sell |
101,200
-800
| -0.8% | -$36K | 0.01% | 536 |
|
|
2022
Q4 | $4.05M | Buy |
102,000
+14,100
| +16% | +$560K | 0.01% | 559 |
|
|
2022
Q3 | $5.79M | Sell |
87,900
-800
| -0.9% | -$52.7K | 0.01% | 480 |
|
|
2022
Q2 | $5.39M | Sell |
88,700
-8,300
| -9% | -$505K | 0.01% | 515 |
|
|
2022
Q1 | $6.27M | Buy |
97,000
+2,900
| +3% | +$187K | 0.01% | 543 |
|
|
2021
Q4 | $7.55M | Buy |
94,100
+18,500
| +24% | +$1.48M | 0.01% | 486 |
|
|
2021
Q3 | $8.5M | Buy |
+75,600
| New | +$8.5M | 0.01% | 446 |
|